The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers - 10/03/21
Key words : basal cell carcinoma, COVID-19, cutaneous melanoma, cutaneous squamous cell carcinoma, diagnostic delay, nonmelanoma skin cancer
Funding sources: None. |
|
IRB approval status: Approved by University of Central Florida IRB (approval 00000863). |
Vol 84 - N° 4
P. 1100-1103 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.